These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 5446563)
1. [Dosage of hydroxocobalamin (Vibeden)]. Skouby AP Ugeskr Laeger; 1970 Jan; 132(5):208-13. PubMed ID: 5446563 [No Abstract] [Full Text] [Related]
2. [Comparison between the durations of the effects of the vitamin B12 preparations Betolvex and Vibeden]. Bastrup-Madsen P Ugeskr Laeger; 1973 Sep; 135(38):2037-41. PubMed ID: 4774011 [No Abstract] [Full Text] [Related]
3. Treatment of vitamin B12 deficiency. Evaluation of therapy with cyanocobalamin, hydroxocabalamin, and depot cobalamin Betolvex. Bastrup-Madsen P Scand J Gastroenterol Suppl; 1974; 29():89-95. PubMed ID: 4530460 [No Abstract] [Full Text] [Related]
4. [Letter: Betolvex and Vibeden]. Kristensen HP Ugeskr Laeger; 1973 Oct; 135(43):2331. PubMed ID: 4775659 [No Abstract] [Full Text] [Related]
5. Case 30-2004: a woman with paresthesias. Davies SV N Engl J Med; 2005 Jan; 352(4):419-20; author reply 419-20. PubMed ID: 15673813 [No Abstract] [Full Text] [Related]
7. Hydroxocobalamin. Excretion and retention of repeated large doses in patients with pernicious anaemia. Killander A; Werner I Acta Med Scand; 1968 Nov; 184(5):393-4. PubMed ID: 5732554 [No Abstract] [Full Text] [Related]
9. Comparison of hydroxocobalamin and cyanocobalamin in the treatment of pernicious anaemia. Chalmers JN; Shinton NK Lancet; 1965 Dec; 2(7426):1305-8. PubMed ID: 4165301 [No Abstract] [Full Text] [Related]
10. [An antibody against a vitamin B 12-binding serum protein (transcobalamin II). A cause of a high content of vitamin B 12 in the serum of patients treated with delayed-action B 12 preparations]. Schwartz M; Hom B; Olesen H; Bastrup-Madsen P Ugeskr Laeger; 1968 May; 130(20):862-6. PubMed ID: 5723667 [No Abstract] [Full Text] [Related]
11. Patient variation in pernicious anaemia, as shown in a clinical trial of cyanocobalamin, hydroxocobalamin and cyanocobalamin--zinc tannate. Tudhope GR; Swan HT; Spray GH Br J Haematol; 1967 Mar; 13(2):216-28. PubMed ID: 6019807 [No Abstract] [Full Text] [Related]
12. Oral or parenteral therapy for vitamin B12 deficiency. Nyholm ES Lancet; 1999 Jan; 353(9150):411. PubMed ID: 9950473 [No Abstract] [Full Text] [Related]
13. Maintenance therapy of pernicious anaemia. Comparison of cyanocobalamin, hydroxocobalamin and a cyanocobalamin-zinc-tannate complex. Killander A; Werner I Acta Haematol; 1968; 40(6):305-14. PubMed ID: 4978697 [No Abstract] [Full Text] [Related]
14. Retention and distribution of B12 activity, and requirement for B12, following parenteral administration of hydroxocobalamin (Vibeden). Skouby AP Acta Med Scand; 1966 Jul; 180(1):95-105. PubMed ID: 5940732 [No Abstract] [Full Text] [Related]
15. Oral or parenteral therapy for vitamin B12 deficiency. Freeman AG Lancet; 1999 Jan; 353(9150):410-1. PubMed ID: 9950472 [No Abstract] [Full Text] [Related]
16. Type I immediate hypersensitivity reaction to cyanocobalamin but not hydroxycobalamin. Moloney FJ; Hughes R; O'Shea D; Kirby B Clin Exp Dermatol; 2008 Jul; 33(4):412-4. PubMed ID: 18498413 [TBL] [Abstract][Full Text] [Related]
17. Hydroxocobalamin. V. Prolonged maintenance of high vitamin B12 blood levels following a short course of hydroxocobalamin injections. Glass GB; Skeggs HR; Lee DH Blood; 1966 Feb; 27(2):234-41. PubMed ID: 5322750 [No Abstract] [Full Text] [Related]
19. [High oral dosage of vitamin B 12 therapy. Experimental basis and practical procedure]. Heinrich HC; Wolfsteller E Med Klin; 1966 May; 61(19):756-63. PubMed ID: 5988322 [No Abstract] [Full Text] [Related]
20. [Evaluation of the body's vitamin B 12 storage during maintenance treatment of pernicious anemia with Betolvex]. Bastrup-Madsen P Ugeskr Laeger; 1966 Mar; 128(9):265-9. PubMed ID: 5915745 [No Abstract] [Full Text] [Related] [Next] [New Search]